ArticleJournal of nanobiotechnology2026
Shikonin-functionalized magnetic nanoparticles mediated magnetothermodynamic therapy with synergistic antibacterial efficacy and immunomodulation for accelerated infected wound healing.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Infected skin wounds healing remains a great clinical challenge due to the complexity of the wound healing process, involving infection control and subsequent immunomodulation. Magnetothermodynamic (MTD) therapy, combining the magnetothermal effect and thermal-amplified Fenton reactivity, is a promising strategy for combating bacterial infections. However, its therapeutic efficacy in wound healing is compromised due to its insufficient ability to address inflammation. Herein, we develop a multifunctional polyvinyl alcohol/gelatin composite hydrogel (MagSK hydrogel) incorporating shikonin-functionalized magnetic nanoparticles (MagSK NPs) to achieve microenvironment-responsive and programmed treatment of infected wounds. During infectious period, MagSK NPs mediated MTD effect can effectively eradicate bacteria and destroy dense biofilm. In subsequent tissue repair stage, MagSK hydrogel suppress excessive inflammation through scavenges reactive oxygen species (ROS), modulates macrophage polarization. Transcriptomic analysis further revealed that the treatment coordinately downregulates inflammatory pathways and upregulates genes critical for tissue proliferation and remodeling. Both in vitro and in vivo studies demonstrate that MagSK hydrogel effectively eliminates bacteria, mitigates inflammation, enhanced angiogenesis and markedly accelerated wound healing. Collectively, our findings highlight a novel strategy for infected wound healing via MagSK-mediated magnetothermodynamic therapy with synergistic antibacterial and immunomodulatory effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.